Canadian Innovation Revolutionizes Menstrual Health Worldwide with the Bfree Cup - The World's First Boil-Free, Antibacterial Menstrual Cup
Proudly made in Canada, the Bfree Cup eliminates the need to boil water to sterilize menstrual products - a barrier in many water-scarce regions. Built-in antimicrobial technology makes it a safe, reusable, and affordable solution for menstruators worldwide. It's not just changing periods, it's changing lives.
More than a product, the Bfree Cup is a symbol of Canadian ingenuity and collaboration. It's helping girls stay in school, reducing stigma, and improving menstrual literacy. WGHI partners with grassroots organizations and NGOs across Africa, Latin America, and Southeast Asia to distribute cups and education, proving that small Canadian enterprises can be powerful players in global health.
Supported by the Fund for Innovation and Transformation (FIT) in partnership with Global Affairs Canada, WGHI introduced the Bfree Cup with partners in multiple countries. FIT's funding and technical support helped transform a bold Canadian idea into a scalable global solution.
"This is exactly what Canadian international assistance can accomplish, and an excellent example of the kinds of transformative, locally-rooted solutions the world needs," says Janice Hamilton, Executive Director. "WGHI's Bfree Cup not only addresses a fundamental health gap, it builds connections between Canadian innovators and communities around the world."
Created by Leisa Hirtz, WGHI's Founder and CEO, the Bfree Cup was shaped by years of research and community input. "Access to safe menstrual care is a human right," says Hirtz. "The Bfree Cup removes barriers of affordability, stigma, and sanitation. It's a game-changer - especially where silence and shame still prevail."
"The school incinerator is in an open space where boys stand and laugh at girls who always come to dispose of their used pads," says a 19-year-old Bfree Cup user and testing participant in rural Uganda. "But now with the Bfree Cup, the boys never know when I am on my period, and this has made me more comfortable in school and also boosted my confidence in school."
With bold vision and deep collaboration, the Bfree Cup is showing what happens when Canadian innovation meets global need. It reminds us that it doesn't take a giant to make change - it takes a village. And this village is just getting started.
Watch "Canadian Innovation Revolutionizes Menstrual Health" PSA Here
#CIW25 #periodfriendlyworld
About FIT
A 7-year, $20.5 M initiative of the Inter-Council Network of Provincial and Regional Councils for International Cooperation, the Fund for Innovation and Transformation is funded by Global Affairs Canada and administered by the Manitoba Council for International Cooperation. FIT is designed to support Canadian small and medium-sized organizations testing innovative solutions that advance gender equality in the Global South. The program supports civil society organizations, social enterprises, post-secondary institutions and the private sector.
About ICN
The Inter-Council Network of Provincial and Regional Councils for International Cooperation is a coalition of the eight Provincial and Regional Councils for International Cooperation. These independent member-based Councils are committed to global social justice and social change and represent more than 350 diverse civil society organizations from across Canada.
About MCIC
A coalition of Manitoba-based organizations involved in international development, the Manitoba Council for International Cooperation (MCIC)'s mission is to support, connect and amplify the work of its members and partners, while directly engaging and collaborating with Manitobans for global sustainability. MCIC encourages dialogue on global issues and helps empower Manitobans to become active global citizens - individuals who understand that their actions here make a difference around the world. MCIC is also responsible for distributing Government of Manitoba and Government of Canada funds designated for international development and humanitarian projects.
About Global Affairs Canada
Global Affairs Canada manages Canada's diplomatic relations, provides consular services to Canadians, promotes the country's international trade, and leads Canada's international development and humanitarian assistance. FIT is a program undertaken with the financial support of the Government of Canada provided through Global Affairs Canada.
Social Media Links:
Facebook:https://www.facebook.com/fit.fit.ca
Twitter:https://twitter.com/fit_fit_ca
Linkedin:https://www.linkedin.com/company/fit-fit/
Instagram:https://www.instagram.com/fit_fit_ca/
SOURCE Fund for Innovation and Transformation (FIT)
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/26/c0049.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
EndoDiagnosis & ENDOSURE Revolutionize Endometriosis Detection in Canada with 30-Minute Non-Invasive Test
Kelowna, Aug. 04, 2025 (GLOBE NEWSWIRE) -- EndoDiagnosis is changing the landscape of women's healthcare with its new role as the sole distributor in Canada for the ENDOSURE Tier 1 diagnostic test for endometriosis. This new diagnostic tool marks a significant shift in how endometriosis is detected and managed, cutting down the average diagnosis time from over eight years to just 30 minutes. In the past, diagnosing endometriosis required invasive laparoscopic surgery. This often meant that patients endured years of pain and a lower quality of life without a proper diagnosis. The ENDOSURE test offers a non-invasive option, boasting 99% accuracy in detecting all stages of the disease in less than an hour. This bypasses the need for surgical procedures. Learn more about EndoDiagnosis and what they offer by visiting their website. EndoDiagnosis Founders – Maria Porcellato, Carolyn Plican, Dr. Mary Ellen Haggerty This development is crucial for addressing a major gap in healthcare. Women suffering from endometriosis symptoms frequently face challenges in receiving the correct diagnosis and treatment. By providing a quick and effective diagnostic tool, ENDOSURE helps healthcare providers make faster, more informed decisions, improving care for those impacted by this chronic illness. Maria Porcellato, CEO of EndoDiagnosis, stated, "We have seen the desperation in patients, clients, and even our own daughters that comes with undiagnosed endometriosis. Our mission centers on empowering both patients and healthcare teams with the decision-support tools they need to make informed decisions about healthcare." The ENDOSURE Tier 1 test is designed for women of any age and provides results on the spot without the need for referrals or lab work. Its non-invasive nature not only spares patients from unnecessary surgical procedures but also enables healthcare professionals to concentrate on therapeutic strategies to manage the disease, preserving both quality of life and fertility. EndoDiagnosis is not just distributing this advanced technology but is also dedicated to ensuring its successful use in clinics throughout Canada. The company offers training and certification for healthcare providers, professional medical education, and awareness programs, along with a provider directory to help patients find testing centers. This initiative places Canada at the forefront of endometriosis care, allowing healthcare professionals to offer their patients both clarity and hope. Carolyn Plican, COO of EndoDiagnosis, stressed the importance of this development, commenting, "This partnership represents more than a business agreement – it's about validating women's experiences and providing the answers they desperately need. When patients understand the root cause of their symptoms, it reduces stress, creates closure, and empowers them to move forward with effective treatment strategies."
Yahoo
8 hours ago
- Yahoo
NYC air quality worsens again amid Canadian wildfire haze
NEW YORK — Hazy skies and low air quality returned to the five boroughs on Monday, as smoke from Canadian wildfires again created a gray scene in the New York skies. All of New York state and almost all of New England was under an air quality alert from the National Weather Service on Monday afternoon. The warning for New York City extended until midnight. 'Air quality is unhealthy for sensitive groups, including older adults, children, and people with heart or lung conditions,' NYC's emergency department wrote on social media. 'You may notice a faint smell of smoke, and low visibility conditions.' It has become a depressingly familiar story for New Yorkers in recent years. Smoke from uncontrolled wildfires in Canada, most of them in the province of Manitoba, has been carried south and east by common wind patterns. The worst air quality in recent years occurred in June 2023, when the smoke became so thick it created an orange haze over the city. However, the subpar air quality has returned to the city in each of the past two summers as well, including multiple times earlier this year. 'Limit outdoor activity, close windows, use air purifiers if available, and consider wearing a high-quality mask if you must go outside and are in a sensitive group,' NYC Emergency Management warned. New York was hardly alone in dealing with poor air quality on Monday. All of Maine, New Hampshire, Massachusetts, Rhode Island, Connecticut and Delaware, along with the majority of Vermont were also under air quality alerts. _____
Yahoo
12 hours ago
- Yahoo
Gates Foundation Announces Catalytic Funding to Spark New Era of Women-Centered Research and Innovation
Investments Through 2030 to Catalyze Innovation in Maternal, Menstrual, Gynecological, and Sexual Health for Women Globally SEATTLE, Aug. 4, 2025 /CNW/ -- The Gates Foundation today announced a $2.5 billion commitment through 2030 to accelerate research and development (R&D) focused exclusively on women's health. It will support the advancement of more than 40 innovations in five critical, chronically underfunded areas—particularly those affecting women in low- and middle-income countries. "For too long, women have suffered from health conditions that are misunderstood, misdiagnosed, or ignored," said Dr. Anita Zaidi, president of the Gates Foundation's Gender Equality Division. "We want this investment to spark a new era of women-centered innovation—one where women's lives, bodies, and voices are prioritized in health R&D." Women's health R&D remains chronically underfunded. Areas such as gynecological and menstrual health, obstetric care, contraceptive innovation, sexually transmitted infections (STIs) solutions (including HIV PrEP for women), and maternal health and nutrition receive limited investment. According to a 2021 analysis, led by McKinsey & Company, just 1% of healthcare research and innovation is invested in female-specific conditions beyond oncology. Critical issues like preeclampsia, gestational diabetes, heavy menstrual bleeding, endometriosis, and menopause, which together affect hundreds of million women, remain deeply under-researched. "Investing in women's health has a lasting impact across generations. It leads to healthier families, stronger economies, and a more just world," said Bill Gates, chair of the Gates Foundation. "Yet women's health continues to be ignored, underfunded, and sidelined. Too many women still die from preventable causes or live in poor health. That must change. But we can't do it alone." To close persistent gaps in funding and research, the foundation is urging governments, philanthropists, investors, and the private sector to co-invest in women's health innovations, help shape product development, and ensure access to treatments for the women and girls who need them most. "This is the largest investment we've ever made in women's health research and development, but it still falls far short of what is needed in a neglected and underfunded area of huge human need and opportunity," said Zaidi. "Women's health is not just a philanthropic cause—it's an investable opportunity with immense potential for scientific breakthroughs that could help millions of women. What's needed is the will to pursue and follow through." The foundation's investment will advance innovation across five high-impact areas of a woman's lifespan: Obstetric care and maternal immunization: Making pregnancy and delivery safer Maternal health and nutrition: Supporting healthier pregnancies and newborns Gynecological and menstrual health: Advancing tools and research to better diagnose, treat, and improve gynecological health and reduce infection risk Contraceptive innovation: Offering more accessible, acceptable, and effective options Sexually transmitted infections (STIs): Improving diagnosis and treatment to reduce disproportionate burdens on women Areas of breakthrough potential include research into the vaginal microbiome, first-in-class therapeutics for preeclampsia, and non-hormonal contraception. Included in the commitment are investments that will support data generation and advocacy to help ensure product uptake and impact upon approval. The five priority areas were selected based on a combination of data and evidence about where innovation can save and improve the most lives, direct insights from women in low- and middle-income countries about their needs and preferences, and the persistently high rates of misdiagnosis caused by gaps in medical knowledge and training. They also reflect the unique challenges faced in low-resource settings, making these areas especially ripe for broader public and private investment to drive meaningful, scalable impact. "We see the consequences of underinvestment in women's health innovation every day when women suffer needlessly, and sometimes lose their lives, because of the gaps in how we understand and treat conditions that uniquely affect them," said Dr. Bosede Afolabi, professor of obstetrics and gynecology at the College of Medicine, University of Lagos. "This commitment brings much-needed attention to the health challenges women face in places where resources are most limited and the burden is highest. It reflects a recognition that women's lives—and the innovations that support them—must be prioritized everywhere." By addressing long-standing gaps in women's health, the investment aims to unlock broader social and economic gains. Research shows that every $1 invested in women's health yields $3 in economic growth, and closing the gender health gap could boost the global economy by $1 trillion per year by 2040. This work supports the foundation's long-term goals through 2045: helping to end preventable deaths of moms and babies; ensuring the next generation grows up without having to suffer from deadly infectious diseases; and lifting millions of people out of poverty, putting them on a path to prosperity. It builds on a 25-year legacy of advancing maternal and child health and supporting women's empowerment globally. The R&D commitment complements the foundation's work supporting the scale-up and delivery of women's health commodities, vaccines such as the HPV vaccine, and child health. About the Gates Foundation Guided by the belief that every life has equal value, the Gates Foundation works to help all people lead healthy, productive lives. In developing countries, we work with partners to create impactful solutions so that people can take charge of their futures and achieve their full potential. In the United States, we aim to ensure that everyone—especially those with the fewest resources—has access to the opportunities needed to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Mark Suzman, under the direction of Bill Gates and our governing board. Media contact: media@ Additional materials are available here: Women's Health Innovation Materials View original content: SOURCE Gates Foundation View original content: Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
